Key result
No clinical data or study results are available in the provided text, which only contains journal editorial board information.
Why the study?
Does aspirin 160 mg/day reduce thrombin generation induced by sodium arachidonate in healthy volunteers?
Population
17 healthy volunteers
Comparison
Aspirin 160 mg/day for 3-5 days vs Baseline condition (without aspirin intake)
Design
Cohort
Follow-up
3-5 days
Authors
Loading...
No results available; leaves open whether aspirin reduces thrombin generation in healthy volunteers.
Does aspirin 160 mg/day reduce thrombin generation induced by sodium arachidonate in healthy volunteers?
Aspirin inhibits thrombin generation triggered by sodium arachidonate-induced platelet activation, suggesting an additional antithrombotic mechanism.
Scazziota et al. (2000) studied this question. No clinical data or study results are available in the provided text, which only contains journal editorial board information.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: